Clinical Trials Browser

Active not recruiting × Non Small Cell Lung Cancer Metastatic × lorlatinib × Clear all

NCT04621188 2025-09-24

Lorlatinib After Failure of First-line TKI in Patients With Advanced ROS1-positive NSCLC (ALBATROS)

Phase 2 Active not recruiting

Non Small Cell Lung Cancer Metastatic